Releases › ICD-10-PCS FY2025
ICD-10-PCS FY2025
Effective 2024-10-01 to 2025-03-31. 78,948 codes in the release.
374added
0revised
61removed
Codes added 374
| Code | Description |
|---|---|
| 00503Z4 | Destruction of Brain using Stereoelectroencephalographic Radiofrequency Ablation, Percutaneous Approach |
| 00K0XZ1 | Map Brain using Connectomic Analysis, External Approach |
| 041309R | Bypass Hepatic Artery to Lower Artery with Autologous Venous Tissue, Open Approach |
| 04130AR | Bypass Hepatic Artery to Lower Artery with Autologous Arterial Tissue, Open Approach |
| 04130JR | Bypass Hepatic Artery to Lower Artery with Synthetic Substitute, Open Approach |
| 04130KR | Bypass Hepatic Artery to Lower Artery with Nonautologous Tissue Substitute, Open Approach |
| 04130ZR | Bypass Hepatic Artery to Lower Artery, Open Approach |
| 041349R | Bypass Hepatic Artery to Lower Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach |
| 04134AR | Bypass Hepatic Artery to Lower Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach |
| 04134JR | Bypass Hepatic Artery to Lower Artery with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 04134KR | Bypass Hepatic Artery to Lower Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 04134ZR | Bypass Hepatic Artery to Lower Artery, Percutaneous Endoscopic Approach |
| 041409R | Bypass Splenic Artery to Lower Artery with Autologous Venous Tissue, Open Approach |
| 04140AR | Bypass Splenic Artery to Lower Artery with Autologous Arterial Tissue, Open Approach |
| 04140JR | Bypass Splenic Artery to Lower Artery with Synthetic Substitute, Open Approach |
| 04140KR | Bypass Splenic Artery to Lower Artery with Nonautologous Tissue Substitute, Open Approach |
| 04140ZR | Bypass Splenic Artery to Lower Artery, Open Approach |
| 041449R | Bypass Splenic Artery to Lower Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach |
| 04144AR | Bypass Splenic Artery to Lower Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach |
| 04144JR | Bypass Splenic Artery to Lower Artery with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 04144KR | Bypass Splenic Artery to Lower Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 04144ZR | Bypass Splenic Artery to Lower Artery, Percutaneous Endoscopic Approach |
| 047K342 | Dilation of Right Femoral Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach |
| 047K352 | Dilation of Right Femoral Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047K362 | Dilation of Right Femoral Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047K372 | Dilation of Right Femoral Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047L342 | Dilation of Left Femoral Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach |
| 047L352 | Dilation of Left Femoral Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047L362 | Dilation of Left Femoral Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047L372 | Dilation of Left Femoral Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047M342 | Dilation of Right Popliteal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach |
| 047M352 | Dilation of Right Popliteal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047M362 | Dilation of Right Popliteal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047M372 | Dilation of Right Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047N342 | Dilation of Left Popliteal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach |
| 047N352 | Dilation of Left Popliteal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047N362 | Dilation of Left Popliteal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047N372 | Dilation of Left Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047P342 | Dilation of Right Anterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach |
| 047P352 | Dilation of Right Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047P362 | Dilation of Right Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047P372 | Dilation of Right Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047Q342 | Dilation of Left Anterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach |
| 047Q352 | Dilation of Left Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047Q362 | Dilation of Left Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047Q372 | Dilation of Left Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047R342 | Dilation of Right Posterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach |
| 047R352 | Dilation of Right Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047R362 | Dilation of Right Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047R372 | Dilation of Right Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047S342 | Dilation of Left Posterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach |
| 047S352 | Dilation of Left Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047S362 | Dilation of Left Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047S372 | Dilation of Left Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047T342 | Dilation of Right Peroneal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach |
| 047T352 | Dilation of Right Peroneal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047T362 | Dilation of Right Peroneal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047T372 | Dilation of Right Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047U342 | Dilation of Left Peroneal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach |
| 047U352 | Dilation of Left Peroneal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047U362 | Dilation of Left Peroneal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 047U372 | Dilation of Left Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach |
| 071 | Lymphatic and Hemic Systems, Bypass |
| 07100Z3 | Bypass Head Lymphatic to Peripheral Vein, Open Approach |
| 07100Z4 | Bypass Head Lymphatic to Central Vein, Open Approach |
| 07100Z7 | Bypass Head Lymphatic to Lymphatic, Open Approach |
| 07100ZK | Bypass Head Lymphatic to Thoracic Duct, Open Approach |
| 07100ZL | Bypass Head Lymphatic to Cisterna Chyli, Open Approach |
| 07104Z3 | Bypass Head Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 07104Z4 | Bypass Head Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 07104Z7 | Bypass Head Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 07104ZK | Bypass Head Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 07104ZL | Bypass Head Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 07110Z3 | Bypass Right Neck Lymphatic to Peripheral Vein, Open Approach |
| 07110Z4 | Bypass Right Neck Lymphatic to Central Vein, Open Approach |
| 07110Z7 | Bypass Right Neck Lymphatic to Lymphatic, Open Approach |
| 07110ZK | Bypass Right Neck Lymphatic to Thoracic Duct, Open Approach |
| 07110ZL | Bypass Right Neck Lymphatic to Cisterna Chyli, Open Approach |
| 07114Z3 | Bypass Right Neck Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 07114Z4 | Bypass Right Neck Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 07114Z7 | Bypass Right Neck Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 07114ZK | Bypass Right Neck Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 07114ZL | Bypass Right Neck Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 07120Z3 | Bypass Left Neck Lymphatic to Peripheral Vein, Open Approach |
| 07120Z4 | Bypass Left Neck Lymphatic to Central Vein, Open Approach |
| 07120Z7 | Bypass Left Neck Lymphatic to Lymphatic, Open Approach |
| 07120ZK | Bypass Left Neck Lymphatic to Thoracic Duct, Open Approach |
| 07120ZL | Bypass Left Neck Lymphatic to Cisterna Chyli, Open Approach |
| 07124Z3 | Bypass Left Neck Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 07124Z4 | Bypass Left Neck Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 07124Z7 | Bypass Left Neck Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 07124ZK | Bypass Left Neck Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 07124ZL | Bypass Left Neck Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 07130Z3 | Bypass Right Upper Extremity Lymphatic to Peripheral Vein, Open Approach |
| 07130Z4 | Bypass Right Upper Extremity Lymphatic to Central Vein, Open Approach |
| 07130Z7 | Bypass Right Upper Extremity Lymphatic to Lymphatic, Open Approach |
| 07130ZK | Bypass Right Upper Extremity Lymphatic to Thoracic Duct, Open Approach |
| 07130ZL | Bypass Right Upper Extremity Lymphatic to Cisterna Chyli, Open Approach |
| 07134Z3 | Bypass Right Upper Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 07134Z4 | Bypass Right Upper Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 07134Z7 | Bypass Right Upper Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 07134ZK | Bypass Right Upper Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 07134ZL | Bypass Right Upper Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 07140Z3 | Bypass Left Upper Extremity Lymphatic to Peripheral Vein, Open Approach |
| 07140Z4 | Bypass Left Upper Extremity Lymphatic to Central Vein, Open Approach |
| 07140Z7 | Bypass Left Upper Extremity Lymphatic to Lymphatic, Open Approach |
| 07140ZK | Bypass Left Upper Extremity Lymphatic to Thoracic Duct, Open Approach |
| 07140ZL | Bypass Left Upper Extremity Lymphatic to Cisterna Chyli, Open Approach |
| 07144Z3 | Bypass Left Upper Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 07144Z4 | Bypass Left Upper Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 07144Z7 | Bypass Left Upper Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 07144ZK | Bypass Left Upper Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 07144ZL | Bypass Left Upper Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 07150Z3 | Bypass Right Axillary Lymphatic to Peripheral Vein, Open Approach |
| 07150Z4 | Bypass Right Axillary Lymphatic to Central Vein, Open Approach |
| 07150Z7 | Bypass Right Axillary Lymphatic to Lymphatic, Open Approach |
| 07150ZK | Bypass Right Axillary Lymphatic to Thoracic Duct, Open Approach |
| 07150ZL | Bypass Right Axillary Lymphatic to Cisterna Chyli, Open Approach |
| 07154Z3 | Bypass Right Axillary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 07154Z4 | Bypass Right Axillary Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 07154Z7 | Bypass Right Axillary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 07154ZK | Bypass Right Axillary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 07154ZL | Bypass Right Axillary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 07160Z3 | Bypass Left Axillary Lymphatic to Peripheral Vein, Open Approach |
| 07160Z4 | Bypass Left Axillary Lymphatic to Central Vein, Open Approach |
| 07160Z7 | Bypass Left Axillary Lymphatic to Lymphatic, Open Approach |
| 07160ZK | Bypass Left Axillary Lymphatic to Thoracic Duct, Open Approach |
| 07160ZL | Bypass Left Axillary Lymphatic to Cisterna Chyli, Open Approach |
| 07164Z3 | Bypass Left Axillary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 07164Z4 | Bypass Left Axillary Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 07164Z7 | Bypass Left Axillary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 07164ZK | Bypass Left Axillary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 07164ZL | Bypass Left Axillary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 07170Z3 | Bypass Thorax Lymphatic to Peripheral Vein, Open Approach |
| 07170Z4 | Bypass Thorax Lymphatic to Central Vein, Open Approach |
| 07170Z7 | Bypass Thorax Lymphatic to Lymphatic, Open Approach |
| 07170ZK | Bypass Thorax Lymphatic to Thoracic Duct, Open Approach |
| 07170ZL | Bypass Thorax Lymphatic to Cisterna Chyli, Open Approach |
| 07174Z3 | Bypass Thorax Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 07174Z4 | Bypass Thorax Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 07174Z7 | Bypass Thorax Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 07174ZK | Bypass Thorax Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 07174ZL | Bypass Thorax Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 07180Z3 | Bypass Right Internal Mammary Lymphatic to Peripheral Vein, Open Approach |
| 07180Z4 | Bypass Right Internal Mammary Lymphatic to Central Vein, Open Approach |
| 07180Z7 | Bypass Right Internal Mammary Lymphatic to Lymphatic, Open Approach |
| 07180ZK | Bypass Right Internal Mammary Lymphatic to Thoracic Duct, Open Approach |
| 07180ZL | Bypass Right Internal Mammary Lymphatic to Cisterna Chyli, Open Approach |
| 07184Z3 | Bypass Right Internal Mammary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 07184Z4 | Bypass Right Internal Mammary Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 07184Z7 | Bypass Right Internal Mammary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 07184ZK | Bypass Right Internal Mammary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 07184ZL | Bypass Right Internal Mammary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 07190Z3 | Bypass Left Internal Mammary Lymphatic to Peripheral Vein, Open Approach |
| 07190Z4 | Bypass Left Internal Mammary Lymphatic to Central Vein, Open Approach |
| 07190Z7 | Bypass Left Internal Mammary Lymphatic to Lymphatic, Open Approach |
| 07190ZK | Bypass Left Internal Mammary Lymphatic to Thoracic Duct, Open Approach |
| 07190ZL | Bypass Left Internal Mammary Lymphatic to Cisterna Chyli, Open Approach |
| 07194Z3 | Bypass Left Internal Mammary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 07194Z4 | Bypass Left Internal Mammary Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 07194Z7 | Bypass Left Internal Mammary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 07194ZK | Bypass Left Internal Mammary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 07194ZL | Bypass Left Internal Mammary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 071B0Z3 | Bypass Mesenteric Lymphatic to Peripheral Vein, Open Approach |
| 071B0Z4 | Bypass Mesenteric Lymphatic to Central Vein, Open Approach |
| 071B0Z7 | Bypass Mesenteric Lymphatic to Lymphatic, Open Approach |
| 071B0ZK | Bypass Mesenteric Lymphatic to Thoracic Duct, Open Approach |
| 071B0ZL | Bypass Mesenteric Lymphatic to Cisterna Chyli, Open Approach |
| 071B4Z3 | Bypass Mesenteric Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 071B4Z4 | Bypass Mesenteric Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 071B4Z7 | Bypass Mesenteric Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 071B4ZK | Bypass Mesenteric Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 071B4ZL | Bypass Mesenteric Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 071C0Z3 | Bypass Pelvis Lymphatic to Peripheral Vein, Open Approach |
| 071C0Z4 | Bypass Pelvis Lymphatic to Central Vein, Open Approach |
| 071C0Z7 | Bypass Pelvis Lymphatic to Lymphatic, Open Approach |
| 071C0ZK | Bypass Pelvis Lymphatic to Thoracic Duct, Open Approach |
| 071C0ZL | Bypass Pelvis Lymphatic to Cisterna Chyli, Open Approach |
| 071C4Z3 | Bypass Pelvis Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 071C4Z4 | Bypass Pelvis Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 071C4Z7 | Bypass Pelvis Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 071C4ZK | Bypass Pelvis Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 071C4ZL | Bypass Pelvis Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 071D0Z3 | Bypass Aortic Lymphatic to Peripheral Vein, Open Approach |
| 071D0Z4 | Bypass Aortic Lymphatic to Central Vein, Open Approach |
| 071D0Z7 | Bypass Aortic Lymphatic to Lymphatic, Open Approach |
| 071D0ZK | Bypass Aortic Lymphatic to Thoracic Duct, Open Approach |
| 071D0ZL | Bypass Aortic Lymphatic to Cisterna Chyli, Open Approach |
| 071D4Z3 | Bypass Aortic Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 071D4Z4 | Bypass Aortic Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 071D4Z7 | Bypass Aortic Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 071D4ZK | Bypass Aortic Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 071D4ZL | Bypass Aortic Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 071F0Z3 | Bypass Right Lower Extremity Lymphatic to Peripheral Vein, Open Approach |
| 071F0Z4 | Bypass Right Lower Extremity Lymphatic to Central Vein, Open Approach |
| 071F0Z7 | Bypass Right Lower Extremity Lymphatic to Lymphatic, Open Approach |
| 071F0ZK | Bypass Right Lower Extremity Lymphatic to Thoracic Duct, Open Approach |
| 071F0ZL | Bypass Right Lower Extremity Lymphatic to Cisterna Chyli, Open Approach |
| 071F4Z3 | Bypass Right Lower Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 071F4Z4 | Bypass Right Lower Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 071F4Z7 | Bypass Right Lower Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 071F4ZK | Bypass Right Lower Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 071F4ZL | Bypass Right Lower Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 071G0Z3 | Bypass Left Lower Extremity Lymphatic to Peripheral Vein, Open Approach |
| 071G0Z4 | Bypass Left Lower Extremity Lymphatic to Central Vein, Open Approach |
| 071G0Z7 | Bypass Left Lower Extremity Lymphatic to Lymphatic, Open Approach |
| 071G0ZK | Bypass Left Lower Extremity Lymphatic to Thoracic Duct, Open Approach |
| 071G0ZL | Bypass Left Lower Extremity Lymphatic to Cisterna Chyli, Open Approach |
| 071G4Z3 | Bypass Left Lower Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 071G4Z4 | Bypass Left Lower Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 071G4Z7 | Bypass Left Lower Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 071G4ZK | Bypass Left Lower Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 071G4ZL | Bypass Left Lower Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 071H0Z3 | Bypass Right Inguinal Lymphatic to Peripheral Vein, Open Approach |
| 071H0Z4 | Bypass Right Inguinal Lymphatic to Central Vein, Open Approach |
| 071H0Z7 | Bypass Right Inguinal Lymphatic to Lymphatic, Open Approach |
| 071H0ZK | Bypass Right Inguinal Lymphatic to Thoracic Duct, Open Approach |
| 071H0ZL | Bypass Right Inguinal Lymphatic to Cisterna Chyli, Open Approach |
| 071H4Z3 | Bypass Right Inguinal Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 071H4Z4 | Bypass Right Inguinal Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 071H4Z7 | Bypass Right Inguinal Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 071H4ZK | Bypass Right Inguinal Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 071H4ZL | Bypass Right Inguinal Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 071J0Z3 | Bypass Left Inguinal Lymphatic to Peripheral Vein, Open Approach |
| 071J0Z4 | Bypass Left Inguinal Lymphatic to Central Vein, Open Approach |
| 071J0Z7 | Bypass Left Inguinal Lymphatic to Lymphatic, Open Approach |
| 071J0ZK | Bypass Left Inguinal Lymphatic to Thoracic Duct, Open Approach |
| 071J0ZL | Bypass Left Inguinal Lymphatic to Cisterna Chyli, Open Approach |
| 071J4Z3 | Bypass Left Inguinal Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach |
| 071J4Z4 | Bypass Left Inguinal Lymphatic to Central Vein, Percutaneous Endoscopic Approach |
| 071J4Z7 | Bypass Left Inguinal Lymphatic to Lymphatic, Percutaneous Endoscopic Approach |
| 071J4ZK | Bypass Left Inguinal Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach |
| 071J4ZL | Bypass Left Inguinal Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 071K0Z3 | Bypass Thoracic Duct to Peripheral Vein, Open Approach |
| 071K0Z4 | Bypass Thoracic Duct to Central Vein, Open Approach |
| 071K0Z7 | Bypass Thoracic Duct to Lymphatic, Open Approach |
| 071K0ZK | Bypass Thoracic Duct to Thoracic Duct, Open Approach |
| 071K0ZL | Bypass Thoracic Duct to Cisterna Chyli, Open Approach |
| 071K4Z3 | Bypass Thoracic Duct to Peripheral Vein, Percutaneous Endoscopic Approach |
| 071K4Z4 | Bypass Thoracic Duct to Central Vein, Percutaneous Endoscopic Approach |
| 071K4Z7 | Bypass Thoracic Duct to Lymphatic, Percutaneous Endoscopic Approach |
| 071K4ZK | Bypass Thoracic Duct to Thoracic Duct, Percutaneous Endoscopic Approach |
| 071K4ZL | Bypass Thoracic Duct to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 071L0Z3 | Bypass Cisterna Chyli to Peripheral Vein, Open Approach |
| 071L0Z4 | Bypass Cisterna Chyli to Central Vein, Open Approach |
| 071L0Z7 | Bypass Cisterna Chyli to Lymphatic, Open Approach |
| 071L0ZK | Bypass Cisterna Chyli to Thoracic Duct, Open Approach |
| 071L0ZL | Bypass Cisterna Chyli to Cisterna Chyli, Open Approach |
| 071L4Z3 | Bypass Cisterna Chyli to Peripheral Vein, Percutaneous Endoscopic Approach |
| 071L4Z4 | Bypass Cisterna Chyli to Central Vein, Percutaneous Endoscopic Approach |
| 071L4Z7 | Bypass Cisterna Chyli to Lymphatic, Percutaneous Endoscopic Approach |
| 071L4ZK | Bypass Cisterna Chyli to Thoracic Duct, Percutaneous Endoscopic Approach |
| 071L4ZL | Bypass Cisterna Chyli to Cisterna Chyli, Percutaneous Endoscopic Approach |
| 0FP480Z | Removal of Drainage Device from Gallbladder, Via Natural or Artificial Opening Endoscopic |
| 0FPG80Z | Removal of Drainage Device from Pancreas, Via Natural or Artificial Opening Endoscopic |
| 0FW480Z | Revision of Drainage Device in Gallbladder, Via Natural or Artificial Opening Endoscopic |
| 0FWG80Z | Revision of Drainage Device in Pancreas, Via Natural or Artificial Opening Endoscopic |
| 0HRT07B | Replacement of Right Breast using Lumbar Artery Perforator Flap, Open Approach |
| 0HRU07B | Replacement of Left Breast using Lumbar Artery Perforator Flap, Open Approach |
| 0HRV07B | Replacement of Bilateral Breast using Lumbar Artery Perforator Flap, Open Approach |
| 0NPB05Z | Removal of External Fixation Device from Nasal Bone, Open Approach |
| 0NPB35Z | Removal of External Fixation Device from Nasal Bone, Percutaneous Approach |
| 0NPB45Z | Removal of External Fixation Device from Nasal Bone, Percutaneous Endoscopic Approach |
| 0NPBX5Z | Removal of External Fixation Device from Nasal Bone, External Approach |
| 0NPW05Z | Removal of External Fixation Device from Facial Bone, Open Approach |
| 0NPW35Z | Removal of External Fixation Device from Facial Bone, Percutaneous Approach |
| 0NPW45Z | Removal of External Fixation Device from Facial Bone, Percutaneous Endoscopic Approach |
| 0NPWX5Z | Removal of External Fixation Device from Facial Bone, External Approach |
| 0NWB05Z | Revision of External Fixation Device in Nasal Bone, Open Approach |
| 0NWB35Z | Revision of External Fixation Device in Nasal Bone, Percutaneous Approach |
| 0NWB45Z | Revision of External Fixation Device in Nasal Bone, Percutaneous Endoscopic Approach |
| 0NWBX5Z | Revision of External Fixation Device in Nasal Bone, External Approach |
| 0NWW05Z | Revision of External Fixation Device in Facial Bone, Open Approach |
| 0NWW35Z | Revision of External Fixation Device in Facial Bone, Percutaneous Approach |
| 0NWW45Z | Revision of External Fixation Device in Facial Bone, Percutaneous Endoscopic Approach |
| 0NWWX5Z | Revision of External Fixation Device in Facial Bone, External Approach |
| 5A05A0L | Extracorporeal Peripheral Veno-venous Filtration, Intraoperative |
| 8E023FZ | Fiber Optic 3D Guided Procedure of Circulatory System, Percutaneous Approach |
| X05133A | Destruction of Renal Sympathetic Nerve(s) using Radiofrequency Ablation, Percutaneous Approach, New Technology Group 10 |
| X27P3TA | Dilation of Right Anterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 |
| X27Q3TA | Dilation of Left Anterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 |
| X27R3TA | Dilation of Right Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 |
| X27S3TA | Dilation of Left Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 |
| X27T3TA | Dilation of Right Peroneal Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 |
| X27U3TA | Dilation of Left Peroneal Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 |
| X28 | New Technology, Cardiovascular System, Division |
| X28F3VA | Division of Aortic Valve using Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach, New Technology Group 10 |
| X2R50WA | Replacement of Right Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 |
| X2R60WA | Replacement of Left Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 |
| X2R70WA | Replacement of Right Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 |
| X2R80WA | Replacement of Left Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 |
| X2RJ3RA | Replacement of Tricuspid Valve with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach, New Technology Group 10 |
| X2VE3SA | Restriction of Descending Thoracic Aorta and Abdominal Aorta using Branched Intraluminal Device, Manufactured Integrated System, Four or More Arteries, Percutaneous Approach, New Technology Group 10 |
| XHR0XGA | Replacement of Head and Neck Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 |
| XHR1XGA | Replacement of Chest Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 |
| XHR2XGA | Replacement of Abdomen Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 |
| XHR3XGA | Replacement of Back Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 |
| XHR4XGA | Replacement of Right Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 |
| XHR5XGA | Replacement of Left Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 |
| XHR6XGA | Replacement of Right Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 |
| XHR7XGA | Replacement of Left Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 |
| XRGA0EA | Fusion of Thoracolumbar Vertebral Joint using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10 |
| XRGB0EA | Fusion of Lumbar Vertebral Joint using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10 |
| XRGC0EA | Fusion of 2 or more Lumbar Vertebral Joints using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10 |
| XRGD0EA | Fusion of Lumbosacral Joint using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10 |
| XRGJ0CA | Fusion of Right Ankle Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10 |
| XRGK0CA | Fusion of Left Ankle Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10 |
| XRGL0CA | Fusion of Right Tarsal Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10 |
| XRGM0CA | Fusion of Left Tarsal Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10 |
| XRH60FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Open Approach, New Technology Group 10 |
| XRH63FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Approach, New Technology Group 10 |
| XRH64FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 10 |
| XRH70FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 to 7 Thoracic Vertebral Joints, Open Approach, New Technology Group 10 |
| XRH73FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 to 7 Thoracic Vertebral Joints, Percutaneous Approach, New Technology Group 10 |
| XRH74FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 to 7 Thoracic Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 10 |
| XRH80FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 8 or more Thoracic Vertebral Joints, Open Approach, New Technology Group 10 |
| XRH83FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 8 or more Thoracic Vertebral Joints, Percutaneous Approach, New Technology Group 10 |
| XRH84FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 8 or more Thoracic Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 10 |
| XRHA0FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracolumbar Vertebral Joint, Open Approach, New Technology Group 10 |
| XRHA3FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracolumbar Vertebral Joint, Percutaneous Approach, New Technology Group 10 |
| XRHA4FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracolumbar Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 10 |
| XRHB0FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbar Vertebral Joint, Open Approach, New Technology Group 10 |
| XRHB3FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbar Vertebral Joint, Percutaneous Approach, New Technology Group 10 |
| XRHB4FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbar Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 10 |
| XRHC0FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 or more Lumbar Vertebral Joints, Open Approach, New Technology Group 10 |
| XRHC3FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 or more Lumbar Vertebral Joints, Percutaneous Approach, New Technology Group 10 |
| XRHC4FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 or more Lumbar Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 10 |
| XRHD0FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbosacral Joint, Open Approach, New Technology Group 10 |
| XRHD3FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbosacral Joint, Percutaneous Approach, New Technology Group 10 |
| XRHD4FA | Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbosacral Joint, Percutaneous Endoscopic Approach, New Technology Group 10 |
| XW0136A | Introduction of Dasiglucagon into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 10 |
| XW0333A | Introduction of Bentracimab, Ticagrelor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW0334A | Introduction of Cefepime-taniborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW0335A | Introduction of Ceftobiprole Medocaril Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW0338A | Introduction of Obecabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW0339A | Introduction of Odronextamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW033BA | Introduction of Orca-T Allogeneic T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW033CA | Introduction of Zanidatamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW033DA | Introduction of Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW033FA | Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW0433A | Introduction of Bentracimab, Ticagrelor Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 10 |
| XW0434A | Introduction of Cefepime-taniborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10 |
| XW0435A | Introduction of Ceftobiprole Medocaril Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10 |
| XW0438A | Introduction of Obecabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 10 |
| XW0439A | Introduction of Odronextamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 10 |
| XW043BA | Introduction of Orca-T Allogeneic T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 10 |
| XW043CA | Introduction of Zanidatamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 10 |
| XW043FA | Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Central Vein, Percutaneous Approach, New Technology Group 10 |
| XW0J3HA | Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10 |
| XW0J3JA | Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10 |
| XW0J3KA | Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10 |
| XW0J3LA | Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10 |
| XW0K3HA | Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0K3JA | Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0K3KA | Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0K3LA | Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0L3HA | Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0L3JA | Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0L3KA | Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0L3LA | Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0M3HA | Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0M3JA | Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0M3KA | Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0M3LA | Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10 |
| XW0U0GA | Introduction of Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System into Joints, Open Approach, New Technology Group 10 |
| XW0V3WA | Introduction of AGN1 Bone Void Filler into Bones, Percutaneous Approach, New Technology Group 10 |
| XW1337A | Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW1437A | Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10 |
| XX25X0A | Monitoring of Blood Flow, Adhesive Ultrasound Patch Technology, New Technology Group 10 |
| XXA | New Technology, Physiological Systems, Assistance |
| XXA536A | Circulatory Filtration, Blood Pathogens, Percutaneous Approach, New Technology Group 10 |
| XXE0X1A | Measurement of Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification, New Technology Group 10 |
| XXE5X2A | Measurement of Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum, New Technology Group 10 |
| XXE5X4A | Measurement of Infection, Positive Blood Culture Small Molecule Sensor Array Technology, New Technology Group 10 |
Codes removed 61
| Code | Description |
|---|---|
| X27H385 | Dilation of Right Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27H395 | Dilation of Right Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27H3B5 | Dilation of Right Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27H3C5 | Dilation of Right Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27J385 | Dilation of Left Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27J395 | Dilation of Left Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27J3B5 | Dilation of Left Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27J3C5 | Dilation of Left Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27K385 | Dilation of Proximal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27K395 | Dilation of Proximal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27K3B5 | Dilation of Proximal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27K3C5 | Dilation of Proximal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27L385 | Dilation of Proximal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27L395 | Dilation of Proximal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27L3B5 | Dilation of Proximal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27L3C5 | Dilation of Proximal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27M385 | Dilation of Distal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27M395 | Dilation of Distal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27M3B5 | Dilation of Distal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27M3C5 | Dilation of Distal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27N385 | Dilation of Distal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27N395 | Dilation of Distal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27N3B5 | Dilation of Distal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27N3C5 | Dilation of Distal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27P385 | Dilation of Right Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27P395 | Dilation of Right Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27P3B5 | Dilation of Right Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27P3C5 | Dilation of Right Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27Q385 | Dilation of Left Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27Q395 | Dilation of Left Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27Q3B5 | Dilation of Left Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27Q3C5 | Dilation of Left Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27R385 | Dilation of Right Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27R395 | Dilation of Right Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27R3B5 | Dilation of Right Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27R3C5 | Dilation of Right Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27S385 | Dilation of Left Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27S395 | Dilation of Left Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27S3B5 | Dilation of Left Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27S3C5 | Dilation of Left Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27T385 | Dilation of Right Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27T395 | Dilation of Right Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27T3B5 | Dilation of Right Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27T3C5 | Dilation of Right Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27U385 | Dilation of Left Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27U395 | Dilation of Left Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27U3B5 | Dilation of Left Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27U3C5 | Dilation of Left Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| XW033K5 | Introduction of Fosfomycin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5 |
| XW033N5 | Introduction of Meropenem-vaborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5 |
| XW033U5 | Introduction of Imipenem-cilastatin-relebactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5 |
| XW043K5 | Introduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5 |
| XW043N5 | Introduction of Meropenem-vaborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5 |
| XW043U5 | Introduction of Imipenem-cilastatin-relebactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5 |
| XW097M5 | Introduction of Esketamine Hydrochloride into Nose, Via Natural or Artificial Opening, New Technology Group 5 |
| XW0DXJ5 | Introduction of Apalutamide Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5 |
| XW0DXL5 | Introduction of Erdafitinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5 |
| XW0DXR5 | Introduction of Venetoclax Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5 |
| XW0DXT5 | Introduction of Ruxolitinib into Mouth and Pharynx, External Approach, New Technology Group 5 |
| XW0DXV5 | Introduction of Gilteritinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5 |
| XXE5XM5 | Measurement of Infection, Whole Blood Nucleic Acid-base Microbial Detection, New Technology Group 5 |